UK markets close in 17 minutes

Kontafarma China Holdings Limited (1312.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.037+0.002 (+5.71%)
At close: 09:53AM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
809,107
809,107
894,062
803,267
1,009,134
Cost of revenue
337,815
337,815
387,841
407,091
453,385
Gross profit
471,292
471,292
506,221
396,176
555,749
Operating expenses
Research development
-
-
-
45,633
35,705
Selling general and administrative
542,492
542,492
558,686
456,810
506,712
Total operating expenses
534,539
534,539
547,647
429,492
504,088
Operating income or loss
-63,247
-63,247
-41,426
-33,316
51,661
Interest expense
15,250
15,250
23,278
33,610
31,435
Income before tax
-43,919
-43,919
-117,736
-54,465
-297
Income tax expense
17,196
17,196
-7,992
1,830
19,788
Income from continuing operations
-61,115
-61,115
-109,744
-56,295
-20,085
Net income
-28,843
-28,843
-41,546
-15,048
-267,164
Net income available to common shareholders
-28,843
-28,843
-41,546
-15,048
-267,164
Basic EPS
0.01
-
-0.01
-0.00
-0.05
Diluted EPS
0.01
-
-0.01
-0.00
-0.05
Basic average shares
5,578,714
-
5,578,714
5,578,714
5,578,714
Diluted average shares
5,578,714
-
5,578,714
5,578,714
5,578,714